GSC
ARCT icon

Ground Swell Capital’s Arcturus Therapeutics ARCT Stock Holding History

Ground Swell Capital’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1K Sell
7
-7
-50% -$912 ﹤0.01% 2077
2014
Q2 		$2K Buy
+14
New +$1.69K ﹤0.01% 1455

Other funds holding ARCT

KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
GL
GLG LLC New York $1.39B AUM 24.01% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
EverPoint Asset Management
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Credit Suisse
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Ground Swell Capital's ARCT Position: Q3 2014 in Review

Ground Swell Capital reduced its Arcturus Therapeutics (ARCT) stake by 50% in Q3 2014, selling an estimated $912 and leaving 7 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2077.

Ground Swell Capital first reported a position in ARCT in Q2 2014 and has held it in 2 quarters since. The position peaked at $2K in Q2 2014. 38 funds tracked by Wall St. Rank hold ARCT as of Q3 2014.

  • Ground Swell Capital held 7 shares of Arcturus Therapeutics worth $1K as of Q3 2014.
  • Ground Swell Capital sold 7 Arcturus Therapeutics shares in Q3 2014, an estimated $912.
  • Arcturus Therapeutics made up ﹤0.01% of Ground Swell Capital's portfolio in Q3 2014, its #2077 holding.
  • Ground Swell Capital first reported a position in Arcturus Therapeutics in Q2 2014 and has held it in 2 quarters since.
  • Ground Swell Capital's Arcturus Therapeutics position peaked at $2K in Q2 2014.
  • 38 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.